THTPA
Thiamine-triphosphatase
Also known as: THTPA_HUMAN, THTPASE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BU02
- Gene
- THTPA
- Ensembl
- ENSG00000259431
- Chromosome
- 14
- Canonical length
- 230 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes an enzyme which catalyzes the biosynthesis of thiamine disphophate (vitamin B1) by hydrolysis of thiamine triphosphate. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
230 residues, UniProt reviewed canonical sequence.
>Q9BU02|THTPA
1 MAQGLIEVER KFLPGPGTEE RLQELGGTLE YRVTFRDTYY DTPELSLMQA DHWLRRREDS
61 GWELKCPGAA GVLGPHTEYK ELTAEPTIVA QLCKVLRADG LGAGDVAAVL GPLGLQEVAS
121 FVTKRSAWKL VLLGADEEEP QLRVDLDTAD FGYAVGEVEA LVHEEAEVPT ALEKIHRLSS
181 MLGVPAQETA PAKLIVYLQR FRPQDYQRLL EVNSSRERPQ ETEDPDHCLGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against THTPA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 25 nTPM
- cerebral cortex: 24 nTPM
- skeletal muscle: 23 nTPM
- hippocampal formation: 21 nTPM
- basal ganglia: 21 nTPM
- choroid plexus: 20 nTPM
Single-cell type
- other brain neurons: 11 nCPM
- oligodendrocytes: 10 nCPM
- bergmann glia: 10 nCPM
- brain excitatory neurons: 8.5 nCPM
- astrocytes: 8.3 nCPM
- brain inhibitory neurons: 8.3 nCPM
Immune cell
- plasmacytoid DC: 19 nTPM
- non-classical monocyte: 16 nTPM
- classical monocyte: 16 nTPM
- naive B-cell: 15 nTPM
- myeloid DC: 15 nTPM
- basophil: 14 nTPM
Brain region
- cerebral cortex: 57 nTPM
- amygdala: 31 nTPM
- white matter: 30 nTPM
- choroid plexus: 30 nTPM
- medulla oblongata: 30 nTPM
- basal ganglia: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.55
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.33
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- dephosphorylation
- generation of precursor metabolites and energy
- thiamine diphosphate biosynthetic process
- thiamine metabolic process
- thiamine diphosphate metabolic process
Molecular functions
- hydrolase activity
- magnesium ion binding
- thiamine triphosphate phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thiamine triphosphatase, eukaryotes
- CYTH domain
- CYTH-like domain superfamily
- Thiamine-triphosphatase
- CYTH domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads THTPA as an antibody target. Whether an autoantibody or antibody against THTPA could matter depends on whether native THTPA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
THTPA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label THTPA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...